Cisapride inhibits meal-stimulated gastric acid secretion and post-prandial gastric acidity in subjects with gastro-oesophageal reflux disease

被引:8
作者
Gardner, JD
Rodriguez-Stanley, S
Robinson, M
Miner, PB
机构
[1] Sci Org Inc, Chatham, NJ 07928 USA
[2] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Fdn Digest Res, Oklahoma City, OK USA
关键词
D O I
10.1046/j.1365-2036.2002.01342.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and aims: KCNQ1 potassium channels in human gastric parietal cells are thought to be involved in gastric acid secretion. As cisapride can inhibit similar channels in other tissues and is an effective treatment for nocturnal heartburn, we examined the effects of cisapride on gastric and oesophageal acidity, gastric emptying and heartburn severity in subjects with gastro-oesophageal reflux disease. Methods: Subjects (n=11) had suffered from heartburn four times or more per week for at least 6 months. Gastric pH and oesophageal pH were measured before, during and after a standard meal ingested over 15 min. Each subject received placebo or 10 mg cisapride orally, 30 min before the beginning of the meal. Meal-stimulated gastric acid secretion was calculated from the amount of HCl required to titrate the homogenized standard meal to pH 2 in vitro and the time required for the pH of the ingested meal to decrease to pH 2 in vivo. Heartburn severity was assessed at 15-min intervals beginning at the end of the meal. Gastric emptying of solids was measured using a [C-13]-octanoic acid breath test. Results: Cisapride significantly decreased meal-stimulated gastric acid secretion by 20%, decreased integrated gastric and oesophageal acidity by 50-60% and transiently increased the expiration of (CO2)-C-13. Cisapride did not significantly alter heartburn severity. Conclusions: The cisapride-induced decreases in meal-stimulated gastric acid secretion, gastric acidity and oesophageal acidity in subjects with gastro-oesophageal reflux disease can account for its beneficial clinical effects. These results also raise the possibility that gastric KCNQ1 potassium channels are important in meal-stimulated gastric acid secretion and possibly in the pathophysiology of gastro-oesophageal reflux disease.
引用
收藏
页码:1819 / 1829
页数:11
相关论文
共 45 条
[1]   A prokinetic approach to treatment of gastroesophageal reflux disease [J].
Achem, SR ;
Robinson, M .
DIGESTIVE DISEASES, 1998, 16 (01) :38-46
[2]   Role of HERG-like K+ currents in opossum esophageal circular smooth muscle [J].
Akbarali, HI ;
Thatte, H ;
He, XD ;
Giles, WR ;
Goyal, RK .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1999, 277 (06) :C1284-C1290
[3]  
[Anonymous], GALL ORG NAT SURV HE
[4]   APPROPRIATE ACID SUPPRESSION FOR THE MANAGEMENT OF GASTROESOPHAGEAL REFLUX DISEASE [J].
BELL, NJV ;
BURGET, D ;
HOWDEN, CW ;
WILKINSON, J ;
HUNT, RH .
DIGESTION, 1992, 51 :59-67
[5]  
Boeckxstaens GE, 1998, AM J GASTROENTEROL, V93, P1823
[6]   Cholecystokinin in transient lower oesophageal sphincter relaxation due to gastric distension in humans [J].
Boulant, J ;
Mathieu, S ;
DAmato, M ;
Abergel, A ;
Dapoigny, M ;
Bommelaer, G .
GUT, 1997, 40 (05) :575-581
[7]   CONCENTRATION OF REFLUXED ACID AND ESOPHAGEAL MUCOSAL INJURY [J].
BREMNER, RM ;
CROOKES, PF ;
DEMEESTER, TR ;
PETERS, JH ;
STEIN, HJ .
AMERICAN JOURNAL OF SURGERY, 1992, 164 (05) :522-527
[8]   [C-13]octanoic acid breath test for gastric emptying of solids: Accuracy, reproducibility, and comparison with scintigraphy [J].
Choi, MG ;
Camilleri, M ;
Burton, DD ;
Zinsmeister, AR ;
Forstrom, LA ;
Nair, KS .
GASTROENTEROLOGY, 1997, 112 (04) :1155-1162
[9]   Endogenous cholecystokinin enhances postprandial gastroesophageal reflux in humans through extrasphincteric receptors [J].
Clavé, P ;
González, A ;
Moreno, A ;
López, R ;
Farré, A ;
Cussó, X ;
D'Amato, M ;
Azpiroz, F ;
Lluís, F .
GASTROENTEROLOGY, 1998, 115 (03) :597-604
[10]   GASTRIC-ACID HYPERSECRETION IN REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE [J].
COLLEN, MJ ;
LEWIS, JH ;
BENJAMIN, SB .
GASTROENTEROLOGY, 1990, 98 (03) :654-661